Skip to main navigation
Skip to main content
Skip to Footer
Google Tag Manager
US
Sandoz Site Directory
Our Work
What We Do
Disease Areas
Quality Generics
Biosimilars
Access to Healthcare
About Us
Who We Are
Where We Do Business
Corporate Responsibility
For Novartis Investors
Contact Us
Doing Business Responsibly
Patients & Customers
Report Side Effects
Product Safety Notices
Information for Customers
Products
News
US Press Releases & News
Media Contacts
Publications
Careers
Job Search
Working at Sandoz US
Diversity & Inclusion
Search
All News
Advanced Search
Basic Search
From Date:
To Date:
Show:
All
Featured News
Media Releases
In the News
Filter By
2019
January
Media Release
/
Jan 07, 2019
Sandoz and Pear Therapeutics Announce US Launch of reSET-O™ to Help Treat Opioid Use Disorder
Read More
2018
December
Media Release
/
Dec 10, 2018
Sandoz Inc. and Pear Therapeutics Obtain FDA Clearance for reSET-O™ to Treat Opioid Use Disorder
Read More
Media Release
/
Dec 06, 2018
Update on Launch Plans for SYMJEPI™ (epinephrine) in the US
Read More
Media Release
/
Dec 06, 2018
Sandoz biosimilar Zarxio™ (filgrastim-sndz) reduced out-of-pocket costs for Medicare patients with breast cancer versus the reference medicine
Read More
November
Media Release
/
Nov 19, 2018
Sandoz and Pear Therapeutics announce launch of reSET® for treatment of patients with Substance Use Disorder
Read More
Media Release
/
Nov 08, 2018
Sandoz Inc. Issues Voluntary Nationwide Recall of One Lot of Losartan Potassium and Hydrochlorothiazide Due to the Detection of Trace Amounts of NDEA (N-Nitrosodiethylamine) Impurity Found in the Active Pharmaceutical Ingredient (API)
Read More
Media Release
/
Nov 02, 2018
Sandoz decides not to pursue US biosimilar rituximab; will focus on robust biosimilar portfolio for unmet access and sustainability needs
Read More
October
Media Release
/
Oct 31, 2018
Sandoz receives US FDA approval for biosimilar Hyrimoz™ (adalimumab-adaz)
Read More
Media Release
/
Oct 23, 2018
Sandoz delivers positive results for proposed biosimilars adalimumab and etanercept
Read More
Media Release
/
Oct 08, 2018
Sandoz Healthcare Access Challenge (HACk) launches in US, seeking digital solutions to local healthcare access challenges
Read More
Search Results Navigation
First page
« first
Previous page
‹ previous
…
Page
3
of 5
Page
4
of 5
Current page
5
of 5
Page
6
of 5
Page
7
of 5
…
Next page
next ›
Last page
last »
Twitter
Tweet
Facebook
Share
Share
Twitter
Facebook
LinkedIn
Email
Jump to Comments
Print
Save
You are here
Home
›
News
›